Get started
Author

Qianqian Ye

NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer’s disease via ATF4-dependent mitochondrial UPR
2024 · Xi Xiong, Jialong Hou, et al. · Cell Death and Disease · 44
Defective Autophagy and Mitophagy in Alzheimer’s Disease: Mechanisms and Translational Implications
2021 · Jie Chen, Hai-Jun He, et al. · Molecular Neurobiology · 36
Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework
2023 · Xi Xiong, Haijun He, et al. · CNS Neuroscience & Therapeutics · 23
PDF
Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson’s Disease
2022 · Xuemiao Zhao, Haijun He, et al. · Frontiers in Aging Neuroscience · 22
PDF
Identification of mitophagy‐associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease
2023 · Shuangjie Qian, Haijun He, et al. · CNS Neuroscience & Therapeutics · 18
PDF
Identification of mitophagy-associated proteins (MAPs) profile as potential plasma biomarkers of idiopathic Parkinson’s disease
2022 · Wen-Wen Wang, Hai-Jun He, et al. · Research Square · 1
PDF
Dexmedetomidine enhances ultrasound-guided sciatic nerve block in rats by reducing perineural capillary permeability via RhoA/ROCK-MLC signaling
2026 · Yiling Lin, Youmei Wu, et al. · Scientific Reports
PDF
A Review of the Scope of Myofascial Release for the Treatment of Chronic Nonspecific Low Back Pain
2026 · Qiaoyi Hu, Chunna Zhou, et al. · Advances in World Medical Research
PDF
Plasma derived phosphoglycerate mutase 5 (PGAM5) as a biomarker for Parkinson’s disease
2022 · Liang Feng, Haijun He, et al. · Research Square
PDF
Works count: 9
Citation count: 144
H-index: 5
I10-index: 5
Year
Topic
Type